![Debjani Singh](/sites/default/files/styles/featured_square_large/public/2024-08/2024-P12408.jpg?h=8f9cfe54&itok=bP5F6U4Y)
Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (25)
- Biology and Soft Matter (1)
- Clean Energy (18)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (5)
- Isotopes (5)
- Materials (37)
- Materials for Computing (6)
- National Security (3)
- Neutron Science (13)
- Nuclear Science and Technology (2)
- Supercomputing (21)
News Topics
- (-) Biomedical (60)
- (-) Chemical Sciences (70)
- 3-D Printing/Advanced Manufacturing (125)
- Advanced Reactors (34)
- Artificial Intelligence (97)
- Big Data (60)
- Bioenergy (92)
- Biology (100)
- Biotechnology (23)
- Buildings (61)
- Clean Water (31)
- Climate Change (104)
- Composites (29)
- Computer Science (195)
- Coronavirus (46)
- Critical Materials (29)
- Cybersecurity (35)
- Decarbonization (82)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (112)
- Environment (198)
- Exascale Computing (40)
- Fossil Energy (6)
- Frontier (44)
- Fusion (57)
- Grid (66)
- High-Performance Computing (90)
- Hydropower (11)
- Irradiation (3)
- Isotopes (55)
- ITER (7)
- Machine Learning (49)
- Materials (145)
- Materials Science (145)
- Mathematics (9)
- Mercury (12)
- Microelectronics (4)
- Microscopy (51)
- Molten Salt (8)
- Nanotechnology (60)
- National Security (71)
- Net Zero (14)
- Neutron Science (134)
- Nuclear Energy (110)
- Partnerships (49)
- Physics (63)
- Polymers (33)
- Quantum Computing (37)
- Quantum Science (71)
- Renewable Energy (2)
- Security (25)
- Simulation (49)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (59)
- Sustainable Energy (130)
- Transformational Challenge Reactor (7)
- Transportation (97)
Media Contacts
![Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227. As new uses for thorium are realized, particularly in medicine, the lab expects the demand for the radioisotope to grow.](/sites/default/files/styles/list_page_thumbnail/public/2021-08/Part%20of%20Th-228%20Team_1.jpg?h=09b6d1d3&itok=1_l1hx2l)
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
![Joseph Pickel has been elected a 2021 fellow of the American Chemical Society. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-08/2021-P05142_0.jpg?h=c74750f6&itok=uUGzy6GP)
Joseph Pickel has been elected a 2021 fellow of the American Chemical Society, or ACS. Pickel supports the Fusion and Fission Energy and Sciences Directorate as environment, safety and health
![An ORNL research team is investigating new catalysts for ethanol conversion that could advance the cost-effective production of renewable transportation. Credit: Unsplash](/sites/default/files/styles/list_page_thumbnail/public/2021-07/catalyst_story_tip_0.jpg?h=78aab1d8&itok=0ieRdqRo)
Oak Ridge National Laboratory researchers have developed a new catalyst for converting ethanol into C3+ olefins – the chemical
![Researchers studying secondary metabolites in the fungus Aspergillus flavus, pictured, found unique mixes of metabolites corresponding to genetically distinct populations. The finding suggests local environmental conditions play a key role in secondary metabolite production, influencing the discovery of drugs and other useful compounds. Credit: Tomás Allen Rush/ORNL, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2021-07/DSC0351.jpg?h=b2d9f031&itok=PNgYY5eW)
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![ORNL’s Sergei Kalinin and Rama Vasudevan (foreground) use scanning probe microscopy to study bulk ferroelectricity and surface electrochemistry -- and generate a lot of data. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/KalininVasudevan_2017-P03014_0.jpg?h=1116cd87&itok=KEEOB4hi)
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/2021-03/gif_high_res.gif)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.